ARROWHEAD PHARMACEUTICALS, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

ARROWHEAD PHARMACEUTICALS, INC. reported Cash And Cash Equivalents At Carrying Value of $184.43 million for the year ending 2021.

  • ARROWHEAD PHARMACEUTICALS, INC. showed an increase of +28.5% in Cash And Cash Equivalents At Carrying Value from 2020 to 2021.
  • This data is from ARROWHEAD PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on November 22, 2021.
  • XBRL data for this metric is available from 2010 to 2021 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 12 years of available data (2010 to 2021), ARROWHEAD PHARMACEUTICALS, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 2,593.6%.
  • Historical annual values: Fiscal year 2021: $184.43 million | Fiscal year 2020: $143.58 million | Fiscal year 2019: $221.80 million | Fiscal year 2018: $30.13 million | Fiscal year 2017: $24.84 million | Fiscal year 2016: $85.37 million | Fiscal year 2015: $81.21 million | Fiscal year 2014: $132.51 million | Fiscal year 2013: $19.11 million | Fiscal year 2012: $3.38 million | Fiscal year 2011: $7.51 million | Fiscal year 2010: $6.85 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: